SOSV portfolio company Prolific Machines recently spoke to FiercePharma following a big milestorne for its photomolecular platform, which uses light and optogenetics to “directly and dynamically” manipulate gene expression in living cells. The company announced it has achieved 21 g/L productivity over 15 days in an intensified fed-batch Chinese hamster ovary (CHO) cell line run […]

At our latest SOSV Deep Tech Live, we sat down with a panel of world leaders in plasma to explore ​how plasma is quickly becoming one of the most important…and misunderstood..forces shaping the future of semiconductors, clean manufacturing, advanced materials, and of course, clean energy. While much of today’s AI conversation centers on LLMs that […]

SOSV portfolio company, Fermeate, recently spoke to AgFunder News following it raised a $2 million Seed round led by Newfund Capital with participation from SOSV, Ajinomoto Group Ventures, Ki Tua Fund, Heuristic Capital Partners, Momentum Capital, Plug and Play, Tesserkat Ventures, and Ag Startup Engine, to bring optogenetics into industrial fermentation. Its platform uses light to precisely control gene expression in living […]

Logos Research has recently started working with a small and very exclusive set of top universities and quant funds. They are a new entrant among mathematical reasoning companies, joining startups such as Axiom, Harmonic, Math.Inc and Logical Intelligence.  Logos stands out for being built by a mixture of world-class mathematicians and quant finance managers, a […]

Fusion energy has long been called the “holy grail” of clean power because in theory it’s cheap, abundant, clean, and safe. Yet despite 100+ years of scientific research and billions in investment, the profound engineering challenges associated with fusion-based power are far from settled.
Join us for a fireside chat with Sir Steven Cowley, Director of the U.S. Department of Energy’s Princeton Plasma Physics Laboratory (PPPL).

Cowley is widely considered one of the most influential fusion scientists, having spent decades at the forefront of plasma physics, which is the technological key to containing fusion reactions for power generation. In his role at PPPL and prior to that as CEO of the UK Atomic Energy Authority, Dr. Cowley has shaped not only the science of plasma, but also the engineering strategies and global policy discussions around fusion power. For his contributions to science, he was appointed a Knight Commander of the Order of the British Empire (KBE).

SOSV portfolio company NOC Energy recently spoke with TechCrunch following its $2.7 million Seed funding led by 360 Capital, with participation from SOSV and Desai VC. NOC Energy is tackling one of the “hardest-to-abate” sectors: heavy industry. While industries like cement and glass typically rely on fossil fuels to reach temperatures of 1,500°C, NOC has developed an induction-based, high-temp electric […]

At our latest SOSV Deep Tech Live, we sat down with Carlos Araque, the CEO and founder of Quaise Energy, to discuss energy’s biggest challenge. But first, to understand Quaise, you have to understand the math of energy. Today, it takes 25 terawatts to power the world. But that number doubles every 25 to 30 […]

Announcing the 2026 VC-Founder Physical AI Matchup, with meetings taking place online between May 11th (Monday) and May 15th (Friday). This virtual event will bring together 250+ startups and 250+ investors for 1:1 meetings online, scheduled at mutually convenient times. In 2025, SOSV Matchups generated over 6,500 one-on-one meetings in categories that included Health Tech, […]

SOSV portfolio company unspun is taking a bold step toward reshaping how clothes are made in the U.S. The company, known for its near-zero-waste weaving technology, is planning to raise $40 million in project-level financing to build 10 factories across the U.S. These facilities will use AI-enabled 3D weaving machines designed to produce garments closer […]

SOSV portfolio company HexemBio recently spoke with Axios following its new $10.4 million Seed funding led by Draper Associates, with participation from SOSV, Seraphim, and others. The company is tackling a core driver of aging: the decline of blood stem cells that power the immune system. While past approaches (gene editing, chemical treatments, or transcription-factor reprogramming) often introduce instability […]